The Nucleus Basalis of Meynert (NBM) is the major cholinergic nucleus providing innervation to the entire cortical mantle. In Lewy body disease (Parkinson's disease and Dementia with Lewy Bodies), NBM degeneration is a key contributor to the characteristic cognitive decline and attentional deficits.
The NBM provides the majority of cortical acetylcholine and is critical for:
In Lewy body disease, NBM neurons undergo alpha-synuclein aggregation, leading to progressive cholinergic deficit that underlies the cognitive symptoms distinguishing DLB from Alzheimer's disease.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:2000056 | Meynert cell |
The NBM demonstrates: [1]
NBM degeneration contributes to: [2]
| Neurotransmitter | Change | Clinical Correlation | [3]
|-----------------|--------|----------------------|
| Acetylcholine | ↓↓ 60-80% | Cognitive impairment |
| GABA | ↓ 20-30% | Neuropsychiatric symptoms |
| Norepinephrine | ↓ 40-50% | Autonomic dysfunction |
| Serotonin | ↓ 30-40% | Depression, apathy |
| Feature | LBD | AD |
|---|---|---|
| NBM neuronal loss | 60-80% | 30-50% |
| Cortical ACh reduction | Severe | Moderate |
| Lewy bodies | Present | Absent |
| Treatment response | Cholinergics helpful | Cholinergics helpful |
The study of Nucleus Basalis Of Meynert Neurons In Lewy Body Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.